title: [Keratomycosis in the area of Tunis: epidemiological data, diagnostic and therapeutic modalities].
abstract: Fungal keratitis is a serious disease involving the visual prognosis. This pathology is not well known in Tunisia. The aim of our study is to determine epidemiological data and clinical and mycological characteristics of fungal keratitis in the area of Tunis (North of Tunisia) and discuss its therapeutic modalities. This is a retrospective study including 19 cases of fungal keratitis collected over a period of 11 years (January 1998-December 2008). The diagnosis of keratomycosis was based on clinical and mycological data. Mycological examination interested corneal scraping including direct examination and culture. The cases of fungal keratitis concerned 13 men and 6 women with a mean age of 48.7 years. The most common risk factors was corneal trauma (47.4%). The mean delay between the first ophthalmic signs and consultation was 17.7 days. Most frequently fungal isolated fungi were Candida albicans (6 cases), followed by Aspergillus spp (5 cases) and Fusarium spp (4 cases). All patients received topical and systemical antifungal therapy. The evolution was favourable in six cases. Three patients retained corneal scars. The surgery was necessary in 7 cases, consisting of a penetrating keratoplasty (5 cases), an enucleating (1 case) and amniotic membrane transplantation (1 case). In conclusion, despite the improvement of diagnosis and treatment of fungal keratitis, its prognosis remains pejorative. This prognosis depends on early diagnosis and choice of antifungal therapy.
authors.affiliation: Laboratoire de parasitologie-mycologie, CHU la Rabta, Tunis, Tunisia. anane.sonia@planet.tn
authors.forename: Sonia
authors.initials: S
authors.lastname: Anane
authors.forename: Narjess
authors.initials: N
authors.lastname: Ben Ayed
authors.forename: Ines
authors.initials: I
authors.lastname: Malek
authors.forename: Amel
authors.initials: A
authors.lastname: Chebbi
authors.forename: Samir
authors.initials: S
authors.lastname: Lejri
authors.forename: Hedi
authors.initials: H
authors.lastname: Bouguila
authors.forename: Emira
authors.initials: E
authors.lastname: Kaouech
authors.forename: Slah
authors.initials: S
authors.lastname: Belhadj
authors.forename: Kalthoum
authors.initials: K
authors.lastname: Kallel
authors.forename: Sayda
authors.initials: S
authors.lastname: Ayed
authors.forename: Emna
authors.initials: E
authors.lastname: Chaker
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000453:epidemiology; D001230:Aspergillus / Q000302:isolation & purification; D002177:Candidiasis / Q000188:drug therapy / Q000453:epidemiology; D002648:Child; D003315:Cornea / Q000382:microbiology; D003316:Corneal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology / Q000601:surgery; D005260:Female; D006801:Humans; D007634:Keratitis / Q000453:epidemiology / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy / Q000453:epidemiology; D012189:Retrospective Studies; D014416:Tunisia / Q000453:epidemiology
chemical_list: D000935:Antifungal Agents